Skip to main content

Table 3 Factors influencing the clinical endpoint in 55 horses that remained healthy (H) and 57 horses that developed insect bite hypersensitivity (IBH)

From: A prospective study on insect bite hypersensitivity in horses exported from Iceland into Switzerland

 

Clinical endpoint

Significance

H (n = 55)

IBH (n = 57)

Fisher’s

P (t-test)

Gender (males:females)

42:13

44:13

Ns

 

Age at import (mean year ± SD)

7.1 ± 1.55

7.5 ± 1.61

 

Ns

Import during the IBH season (N/%)

31 (56%)

26 (46%)

Ns

 

Import out of the IBH season (N/ %)

24 (44%)

31 (54%)

Ns

Mean number ± SD of summers since import until clinical outcomea

3.6 ± 0.8

2.8 ± 1

 

≤ 0.001

Mean number ± SD of months since import until clinical outcomea

39 ± 10

30 ± 12

 

≤ 0.001

  1. For this part of the study, only horses that had spent three or more summers in Switzerland were included in the healthy endpoint group
  2. aDefined as time until diagnosis of IBH was first made or, in the healthy group, time point until which horses were monitored without showing clinical signs of IBH